Obesity
- PMID: 38739920
- DOI: 10.7326/AITC202405210
Obesity
Abstract
Obesity is a common condition and a major cause of morbidity and mortality. Fortunately, weight loss treatment can reduce obesity-related complications. This review summarizes the evidence-based strategies physicians can employ to identify, prevent, and treat obesity, including best practices to diagnose and counsel patients, to assess and address the burden of weight-related disease including weight stigma, to address secondary causes of weight gain, and to help patients set individualized and realistic weight loss goals and an effective treatment plan. Effective treatments include lifestyle modification and adjunctive therapies such as antiobesity medications and metabolic and bariatric surgery.
Conflict of interest statement
Similar articles
-
Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.Curr Obes Rep. 2015 Jun;4(2):287-302. doi: 10.1007/s13679-015-0155-x. Curr Obes Rep. 2015. PMID: 26627223 Review.
-
Update on Endoscopic Treatments for Obesity.Curr Obes Rep. 2024 Jun;13(2):364-376. doi: 10.1007/s13679-024-00551-6. Curr Obes Rep. 2024. PMID: 38388770 Review.
-
Treating the Chronic Disease of Obesity.Med Clin North Am. 2021 Nov;105(6):983-1016. doi: 10.1016/j.mcna.2021.06.005. Med Clin North Am. 2021. PMID: 34688422 Review.
-
Review of Advances in Anti-obesity Pharmacotherapy: Implications for a Multimodal Treatment Approach with Metabolic Surgery.Obes Surg. 2019 Dec;29(12):4095-4104. doi: 10.1007/s11695-019-04206-7. Obes Surg. 2019. PMID: 31650405 Review.
-
What is Obesity?: Definition as a Disease, with Implications for Care.Gastroenterol Clin North Am. 2023 Jun;52(2):261-275. doi: 10.1016/j.gtc.2023.03.001. Epub 2023 Apr 7. Gastroenterol Clin North Am. 2023. PMID: 37197872 Review.
Cited by
-
The Median Effective Dose of Ciprofol Combined with Sufentanil for Inhibiting Responses to Gastroscope Insertion in Obese Patients: A Prospective, Single-Center Study.Drug Des Devel Ther. 2025 May 1;19:3577-3587. doi: 10.2147/DDDT.S494972. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40330816 Free PMC article.
-
Impact of the Triglyceride-Glucose index on all-cause and cardiovascular mortalities across different metabolic health and obesity statuses in US adults.BMC Public Health. 2025 May 14;25(1):1767. doi: 10.1186/s12889-025-22901-2. BMC Public Health. 2025. PMID: 40369462 Free PMC article.
-
Temporal trends, associated risk factors and longitudinal cardiovascular outcomes of body roundness among middle-aged and older Chinese adults: from the China Health and Retirement Longitudinal Study 2011-2018.Front Nutr. 2025 Jan 24;12:1515067. doi: 10.3389/fnut.2025.1515067. eCollection 2025. Front Nutr. 2025. PMID: 39927280 Free PMC article.
-
Association between systemic immune inflammation index and adolescent obesity in a cross-sectional analysis.Sci Rep. 2025 Feb 22;15(1):6439. doi: 10.1038/s41598-025-91125-6. Sci Rep. 2025. PMID: 39987171 Free PMC article.
-
Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies.J Clin Med. 2025 May 28;14(11):3791. doi: 10.3390/jcm14113791. J Clin Med. 2025. PMID: 40507553 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical